Although the PrPC-positive rates may vary between different cancer cell types, collectively these data demonstrate that increased PrPC expression closely associates with the pathological degree and clinical progression of human cancers, while emphasizing a common molecular mechanism underlying the contributory role of PrPC in tumor progression. The gene discussed is PRNP; the disease is cancer.